Walking Tall App for Parkinson's (NCT07380737)
Improve gait through smartphone training
- Trial ID
- NCT07380737
- Official Title
- Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study
- Goal
- Improve gait through smartphone training
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinson's Disease
- Interventions
- Walking Tall App
Summary For Families
The aim is to see if a smartphone app can help people with Parkinson's practice gait and balance exercises at home to improve walking quality and confidence between clinic visits. The Walking Tall App guides tailored walking exercises, uses your phone to cue steps and timing, tracks walking patterns, and gives feedback so you can work on step length, rhythm, and stability alongside your usual rehab. They are enrolling adults 40 to 85 with idiopathic Parkinson's at Hoehn and Yahr stage II or III while ON medication, who can walk independently for at least five minutes, have had stable medications for a month, are enrolled in the Ezra LeMarpe rehab program, and can use a smartphone. People with major cognitive problems, other conditions that affect gait, serious cardiovascular contraindications, or inability to use a smartphone are excluded.
Locations
- Tel Aviv Sourasky Medical Center (Ichilov Hospital), Tel Aviv, Israel
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Walking Tall App. The aim is to see if a smartphone app can help people with Parkinson's practice gait and balance exercises at home to improve walking quality and confidence between clinic visits. The Walking Tall App guides tailored walking exercises, uses your phone to cue steps and timing, tracks walking patterns, and gives feedback so you can work on step length, rhythm, and stability alongside your usual rehab. They are enrolling adults 40 to 85 with idiopathic Parkinson's at Hoehn and Yahr stage II or III while ON medication, who can walk independently for at least five minutes, have had stable medications for a month, are enrolled in the Ezra LeMarpe rehab program, and can use a smartphone. People with major cognitive problems, other conditions that affect gait, serious cardiovascular contraindications, or inability to use a smartphone are excluded.
- Who can participate?
- Participants must be between 40 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 8 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive); Wearable / at-home monitoring (non-invasive). Confirm the full schedule with the study coordinator.